Abstract: Irritable bowel syndrome (IBS) patients frequently experience affective disorders and psychiatric outpatients frequently meet criteria for IBS. The exact nature of this co-morbidity is not clear. 34 patients with Rome-II diagnosed IBS were recruited from a Gastroenterology clinic. Patients with social anxiety disorder (10 SSRI-remitted and 7 untreated subjects) were used as a psychiatric comparison, 28 normal subjects from our register were included as a fourth group (Volunteers). Depressive and anxiety symptoms were measured by the Beck Depression Inventory (BDI) and Spielberger Trait Anxiety Inventory (STAI), respectively. Personality traits were measured with the Swedish universities Scales of Personality (SSP). IBS subjects had BDI and STAI scores intermediate between those of volunteers and patients, despite their lack of a co-morbid psychiatric diagnosis. A principle component factor analysis of the SSP dataset corresponded closely to the solution published with other samples. ANOVA revealed significant between-group differences for 7 of the 13 SSP variables.
INTRODUCTION
Irritable bowel syndrome (IBS) is a common condition, with estimated prevalence rates of 10-15% [1] . There is considerable evidence for co-morbidity between IBS and affective disorders [2, 3] although the relationship is complex [4] . For example in gastroenterology clinics, recently referred IBS patients have more anxiety than depressive symptoms [5] , whereas more chronic attendees have less anxiety than depression [6] . The reasons for this are likely confounded by factors such as age, chronicity, help-seeking behaviours and family history [7] [8] [9] .
Functional somatic syndromes, including IBS, have been shown to be associated with depression or anxiety at a higher rate than either healthy controls or subjects with phenomenologically-similar medical complaints of known organic pathology [3] .
Personality factors in IBS have been relatively understudied, and the first study to recruit subjects from a representative community sample with physician diagnosis was only recently published [10] . This study compared IBS patients, IBS non-consulting subjects and normal controls recruited from the Swedish population registry using the Karolinska Scales of Personality (KSP) and Symptom Checklist 90 *Address correspondence to this author at the School of Psychiatry & Clinical Neurosciences (M521), University of Western Australia, QEII Medical Centre, Perth 6009, Australia; E-mail: sean.hood@uwa.edu.au (SCL-90). IBS subjects who had not consulted a physician had similar scores to IBS patients on most measures; both IBS groups differed from controls on personality, interpersonal, and psychological distress measures.
A clearer understanding of the personality and negative affectivity characteristics of IBS patients is essential to ensure targeted and effective treatments for this condition. This is especially important given that both pharmacotherapy (SSRIs) and psychological treatments (Cognitive Behavioural Therapy -CBT) that are mainstream treatments for mood disorders are being increasingly used in IBS with some efficacy [11, 12] .
The aim of the present study was to assess personality using an enhanced version of the KSP in a well defined group of IBS patients attending an outpatient gastroenterology service. We wanted to compare personality and negative affectivity ratings with a well defined physician diagnosed group of patients with an anxiety disorder and an age matched volunteer group. A cohort of patients with untreated and treated social anxiety disorder (SAnD) was available to us at the time this study was conducted. This provided a convenient anxiety disorder comparator that reflected the full range of clinical anxiety severity. Our clinical and research experience [13, 14] is that patients with untreated SAnD exhibit very high levels of anxiety as measured by the assessment scales used here.
Our hypotheses were that IBS patients would be more anxious and have higher depression scores than volunteers but lower than untreated SAnD patients. If correct this would support the common clinical observation that IBS patients, whilst not suffering from clinically significant psychopathology, may experience subsyndromal mood/anxiety symptoms and personality traits that may be relevant to treatment options and clinical outcome.
MATERIALS AND METHODOLOGY

Subjects
All of the subjects in this study (see Table 1 for numbers) had agreed to participate in a series of studies investigating the role of the monoamine systems in either SAnD or IBS. The local regional ethics committee approved these studies; supplemental results will be presented in future papers. The IBS patients were recruited by JQS from a gastroenterology outpatient clinic held at the Bristol Royal Infirmary (ie: IBSconsulters). Patients with SAnD came from the Psychopharmacology Unit outpatient department at the same hospital and were under the clinical care of SDH and JP. The normal volunteers were recruited from a volunteer register held at the Psychopharmacology Unit. All subjects, including volunteers, were assessed for medical and psychiatric comorbidity prior to entry into this study by clinical interview (JH) and supplementary rating scales as indicated; co-morbid subjects were excluded. No subject had a current or recent (6 months) co-morbid DSM-IV diagnosis, or other significant medical condition. Remitted SanD subjects were taking a serotonergic medication (paroxetine); no other subjects were taking a serotonergic or psychotropic medication. Subjects were not paid for their participation, and decision to enter into the study did not influence clinical care.
Bowel habit was assessed according to Rome II Criteria, and IBS subtype classified as constipation-predominant (C-IBS), diarrhoea-predominant (D-IBS), or alternating (A-IBS) according to established convention [15] .
Measures
Basic demographic data were collected by clinical interview.
Depressive symptoms in the studies were measured by the Beck Depression Inventory (BDI) [16] . Trait anxiety was recorded using the Spielberger State-Trait Anxiety Inventory, Trait Scale (STAI) [17] .
Personality traits were measured with the Swedish universities Scales of Personality (SSP) [18] . The SSP is a shortened and psychometrically enhanced version of the Karolinska Scales of Personality (KSP) [19] that improves upon face validity, internal consistency and response differentiation. The SSP contains 91 items divided into 13 scales with seven items each: Somatic Trait Anxiety, Psychic Trait Anxiety, Stress Susceptibility, Lack of Assertiveness, Detachment, Embitterment, Trait Irritability, Mistrust, Impulsiveness, Adventure Seeking, Social Desirability, Verbal Trait Aggression, and Physical Trait Aggression. The items are rated on a 4-point Likert scale, where 1 = "Does not apply at all", 2= "Does not apply very well", 3= "Applies pretty much" and 4 ="Applies completely". The SSP was standardized in a representative national sample of 741 Swedes in which Cronbach's alpha values varied between 0.59 and 0.84. The three-factor solution in the original publication corresponds to well-known personality theories [20] : Factor 1 is related mainly to Neuroticism, Factor 2 is related to Aggressiveness and Factor 3 forms a broad Extraversion factor. This structure has recently been confirmed in a large community sample of women [21] .
Normative standard scores (T-scores) are calculated for each gender separately. In the original work the T-scale is constructed to have a mean of 50 and a SD of 10. Our clinicians have consistently found it to be more useful to construct the T-scale with a mean of 0 using the same standard deviation of 10. In this method, the magnitude as well as direction of deviation from the mean is more apparent in graphical representations, and we can more easily convey these results to our patients. This latter method is used in this article.
Statistical Analyses
The statistical analysis was conducted using SPSS v11.5 for Windows (SPSS Inc, Chicago, IL, USA). An alpha level of 0.05 was used, with the Bonferroni adjustment applied to all pair wise tests. Confidence intervals are displayed where available. Waller-Duncan post-hoc analysis, with Type I/Type II Error Seriousness Ratio = 100, was also used to elucidate homogeneous subsets [22] .
Principal components factor analysis was performed on the complete SSP data set. The Kaiser criterion was applied to exclude eigenvalues less than 1 and the scree plot was reviewed. Orthogonal (Varimax) rotation was undertaken and the limit for factor loadings set to 0.45, as in other analyses of SSP data [23] .
Levene's Test was used to verify equality of variances; non parametric tests are used when equality is not demonstrated. Two-sided tests are employed throughout. Pearson correlation co-efficients were reported after examining scatter plots.
RESULTS
Characteristics of the Sample
Demographic data from the 79 subjects in this study are presented in Table 1 . There were significantly more men than women in the SAnD pre treatment group (X 2 =7, df=1, p=0.008), and more women than men in the C-IBS (X 2 =4.455, df=1, p=0.035) subgroup. No significant impact of sex on BDI (Kruskal-Wallis X 2 = 2.122, df=1, p=0.145) or STAI (Kruskal-Wallis X 2 = 0.412, df=1, p=0.521) was seen. There was no difference in age between any subject group, and the age of this sample was remarkably similar to the mean age of 40.9 years (SD = 12.7) cited in the SSP validation data [18] . Only two IBS patient met criteria for the A-IBS group; this small group was thus excluded from subsequent statistical analyses.
BDI
Significant between-group differences were shown for BDI means (F[3,42] = 12.025, p<0.001). Volunteers had the lowest scores, which were significantly less than those of IBS subjects (p=0.019, 95% CI = -0.75 to -12.48), post treatment SAnD (p=0.01, 95% CI = -3.47 to -16.89) and pre treatment SAnD groups (p<0.001, 95% CI = -7.79 to -22.58). IBS patients also had significantly lower scores than pre treatment SAnD groups (p=0.005, 95% CI = -1.93 to - 15.20) . No other between-group (Bonferroni-adjusted) comparison reached statistical significance. There was no relationship between age (r = -0.155, p=0.305) or sex (Z = -1.424, p=0.154) and BDI. Waller-Duncan analysis confirms the trend suggested in Fig. (1) of three distinct subgroups at alpha = 0.05; namely a volunteer group (mean = 1.70), a combined IBS and SAnD post treatment group (means = 8.32, 11.88 respectively), and a SAnD pre-treatment group (mean = 16.88). 
Spielberger Trait
Significant between-group differences were also seen in STAI scores (F[3,42] = 11.600, p<0.001). Again, volunteers had the lowest STAI scores, which were lower than those of IBS patients (p=0.014, 95% CI = -2.24 to -28.03), post treatment SAnD subjects (p<0.001, 95% CI = -11.39 to -40.91) and pre treatment (p<0.001, 95% CI = -13.63 to -46.17) SAnD subject results (see Fig. 2 ). IBS subjects results were also less than those of pre treatment SAnD subjects (p=0.046, 95% CI= -0.17 to -29.36). There was no effect of age (r= -0.149, p=0.322) or sex (Z=-0.563, p=0.574) on STAI. Waller-Duncan analysis yielded three distinct subgroups; viz a volunteer group (mean = 27.55), an IBS group (mean = 42.68), and a combined SAnD post-and pre-treatment group (means = 53.70, 57.45 respectively).
SSP
The principal component factor analysis for the complete data set is displayed in Table 2 . Factor 1 consisted of 8 items measuring anxiety and negative emotions that will be referred to as Neuroticism (N). Factor 2 consisted of verbal and physical trait aggression and will be referred to as Aggressiveness (A). Factor 3 consisted of impulsiveness and adventure seeking and will be summarised as Sensation Seeking (SS). Cronbach's alpha for these three factors was 0.90, 0.48, 0.57 respectively.
Subgroup factor analyses were not performed due to sample size limitations [24] .
One-way ANOVA revealed significant between-group differences for 7 of the 13 SSP variables, viz: Somatic Trait   Fig. (1) . 95% Confidence Interval of Beck Depression Inventory Score by Subject Group. Table 3 , restricted to results involving the IBS patient subgroup. Table 4 presents SSP variables that separate into homogenous subsets at alpha = 0.05 by Waller-Duncan analysis according to subject group.
IBS Subtype Analysis
There was no difference between C-IBS and D-IBS subjects according to BDI (p=0.854, 95% CI = -4.291 -3.591) or STAI (p=0.957, 95% CI = -11.162 -10.595). C-IBS subjects scored less on the Lack of Assertiveness scale than did D-IBS subjects (Kruskal-Wallis X 2 = 4.536, df=1, p=0.033), however no other significant differences were demonstrated. The SSP results are presented in Fig. (3) .
DISCUSSION
The BDI and STAI findings reported here confirm our clinical impression that patients with IBS often have anxiety and depressive scores at an intermediate level between normal volunteers and patients with clinical anxiety syndromes such as SAnD. Our results also demonstrate a tendency for IBS patients to experience anxiety at levels less than those seen in patients with SAnD who are currently clinically SSRI-remitted. This may reflect residual vulnerability and / or subsyndromal impairment in SSRI-remitted patients with anxiety disorders such as SAnD.
The relevance of these subsyndromal anxiety and depressive scores in IBS patients is not known. A recent study demonstrated a significant role of chronic life stress as a predictor of IBS symptom intensity over 16 months, but found that BDI or STAI score did not significantly impact upon longitudinal symptom intensity [25] .
The mainstays of treatment for anxiety disorders are SSRIs and CBT, both of which are increasingly being used in the management of IBS. The SSRI paroxetine has been shown to improve abdominal pain, constipation and diarrhea associated with IBS, independent of lifetime history of an anxiety disorder [26] although our results suggest that subsyndromal anxiety may be relevant. It is not clear whether SSRI treatment of IBS is reducing this subsyndromal anxiety or whether their mechanism of action is via a direct effect on the gut, and research clearly needs to focus on this.
In terms of CBT, Lackner et al. recently demonstrated that catastrophizing cognitions account for part of the relationship between depression and pain in IBS patients [27] suggesting a complex interplay of physiological, behavioral, and psychological factors. The relationship of IBS to psychological symptoms such as depression is complex, however, with a case report providing evidence that depressive symptoms may be associated with a reduction of IBS symptoms in certain individuals [28] .
The SSP questionnaire is an increasingly popular measure of personality structure [21, 23, [29] [30] [31] . Additionally, the authors' have (anecdotally) found it to be a useful measure in routine clinical psychiatric practice [32] . In our experience, patients with anxiety difficulties score positively on the variables somatic trait anxiety, psychic trait anxiety and stress susceptibility. Moreover, a score above 10 (ie: +1 SD) usually reflects a clinically evident trait and a score above 20 (ie: +2 SD) almost invariably corresponds with a clinically evident impairment. Interestingly, we also find that clinical recovery is mirrored by a normalisation of these SSP variables, making this a useful tool to track progress collaboratively with our patients. Fig. (4) shows the personality characteristics of IBS patients as measured by SSP. It is clear from this graph that these scores are all within +/-1 SD of the general population mean (ie: +/-10), despite 3 of the 13 scales being significantly greater than those of our normal volunteers. These three indices (Somatic Trait Anxiety, Psychic Trait Anxiety, and Stress Susceptibility) describe personality aspects closely related to clinical anxiety syndromes, and the SAnD subjects rate particularly high on these. These results concur with the Karolinska Scales of Personality ratings in the Weinryb et al. study that showed higher scores for IBS patients than controls on four of five anxiety proneness scales [10] . Thus, our IBS subjects demonstrated subsyndromal anxiety and depressive symptoms in the context of normal SSP personality profiles. Normal volunteers were screened to ensure the absence of anxiety disorders, which is reflected in their personality profiles.
Treatment seeking for IBS has been associated with an increase in the tendency to make somatic attributions for both gastroenterological symptoms and symptoms characteristic of depression and anxiety states [33] . A logistic regression analysis in a population of nurses showed that subjects reporting a higher degree of neuroticism were at higher risk of being diagnosed with IBS [34] . Additionally, a study of ethnic Chinese subjects found that in patients with IBS the mean depression score of patients who sought any medical consultation was higher than that of those who did not [35] . The degree of anxiety, but not depressive illness was an independent factor associated with health care-seeking behaviour. The results from the SSP instrument in our study showed that IBS subjects had significantly lower levels of both somatic and psychic anxiety variables than SAnD patients with both variables rated at less than 1 SD away from the general population mean.
A recent cluster analysis of IBS treatment non-responders yielded three distinct groups: a psychiatrically-distressed high service utiliser group (group I), a psychiatricallydistressed low service utiliser group (group II), and a tolerant group of low service utilisers (group III) [36] . Group III had more subjects with C-IBS symptoms than the other groups, and low levels of anxiety, consultation and pain. The IBS subtype analyses performed here produced only one significant finding, namely that C-IBS subjects demonstrated lower Lack of Assertiveness SSP scores than D-IBS patients. Thus, our sample of C-IBS patients was more able to assert themselves in social situations [18] than those with D-IBS symptoms. Just how comparable our C-IBS cohort is to the Group III subjects of the other study is unclear, especially as these patients were less likely to present for treatment.
There are a number of potential limitations of this study that warrant discussion.
This study included IBS patients who were seeking treatment, and who had agreed in principle to take part in a study. No patient with IBS and a co-morbid depressive or anxiety disorder was eligible for inclusion in this study, although only approximately 5% of patients seen in our gastroenterology clinic were excluded on this criterion. These selection biases may limit generalisation to other persons with IBS.
More women than men were seen in our sample of C-IBS patients, although the total IBS sample was sex-balanced. There is considerable evidence of a predominance of women with C-IBS type symptoms in other reports [37, 38] , although this is not invariably found [39] . Our sample did contain more men than women with pre-treatment SAnD; however there was no significant impact of sex on BDI or STAI, and SSP data is sex-adjusted. Post-hoc analysis of the baseline demographic data is otherwise unremarkable.
The BDI and STAI scales were chosen due to their common use in this field and the availability of these data; nevertheless we are aware of the potential for symptom overlap with somatic symptoms of IBS. (Fig. 3) contd….. ( Fig. 4) contd….. Fig. (4) . Average SSP T-Scores. The factor analysis may be underpowered. There is little consensus in this area, as although some authors recommend that the subjects-to-variables ratio should be no lower than 5 (ie: n= 75) [24] or that there should be 51 more cases than the number of variables, to support X 2 testing (ie: n= 63) [40] , others recommend up to 300 cases [41] .
SSP -SAD Post Treatment Patients
CONCLUSION
In conclusion, we have used the SSP questionnaire and the other measures presented here to describe the psychological profiles of patients with IBS in comparison with both a normal volunteer group and a group of patients with an anxiety disorder. We have shown that patients with IBS presenting to a gastroenterology service have anxiety scores that are intermediate between that seen in patients with a syndromal anxiety disorder and that of normal volunteers. Further, character traits as assessed by the SSP reflect those seen in patients with a DSM-IV anxiety disorder with levels of somatic trait anxiety, psychic trait anxiety and stress susceptibility being intermediate between untreated patients with social anxiety disorder and normal volunteers. Despite this intermediate status, IBS patients as a group had normal SSP profiles. This may suggest that the depressive and anxious tendency of IBS subjects are not related to personality factors, although such a finding is speculative. IBS subtypes differed only with respect to the Lack of Assertiveness variable, which is a finding of uncertain clinical relevance that would benefit from replication in future studies.
It is also clear that whilst pharmacological treatment of patients with anxiety disorders is associated with improved anxiety ratings, the residual level of psychological impairment as defined by these scales still differed significantly from normal volunteers. It would be interesting to see whether successful treatment of patients with IBS normalise these scores and whether stress susceptibility is characterised by altered HPA and autonomic axes responses to appropriate challenge tests. Studies to investigate this are currently underway and we look forward to ongoing refinement of this understanding in future publications.
